PCR Mutation Detection Protocols pp 87-108 | Cite as
The Protein Truncation Test
- 1.7k Downloads
Abstract
The protein truncation test (PTT) (1), occasionally referred to as the in vitro synthesized-protein (IVSP) assay (2), is a method for screening the coding region of a gene for mutations that result in the premature termination of mRNA translation. The techniques involved in performing PTT are relatively straightforward and begin with the isolation of genomic DNA or RNA. The polymerase chain reaction (PCR) is used to amplify a DNA template, usually of 1–3 kb in size, that is tested in an in vitro transcription and translation assay. Truncated proteins are identified by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography or fluorography. A single, large exon of a gene can be amplified directly from genomic DNA in several overlapping fragments. The complete coding sequence of a large gene, with many small exons, can be amplified in several overlapping fragments by reverse-transcription PCR (RT-PCR) starting from RNA. Amplifying the gene in several segments that overlap each other by 300–500 bp increases the sensitivity of PTT. A truncating mutation located toward the 3′ end of one segment will also occur near the 5′ end of the next overlapping segment, thus increasing the likelihood of identifying a truncated protein. A specially modified forward PCR primer is required for PTT. In addition to the in-frame gene-specific primer sequence, an extension at the 5′ end includes the T7 promoter sequence for RNA transcription by T7 RNA polymerase, the eukaryotic consensus sequence for the initiation of protein translation, and the ATG protein translation start site.
Keywords
Duchenne Muscular Dystrophy Truncate Mutation Dystrophin Gene Label Amino Acid Truncated ProteinReferences
- 1.Roest, P. A. M., Roberts, R. G., Sugino, S., van Ommen, G-J. B., and den Dunnen, J. T. (1993) Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum. Mol. Genet. 2, 1719–1721.PubMedCrossRefGoogle Scholar
- 2.Powell, S. M., Petersen, G. M., Krush, A. J., Booker, S., Jen, J., Giardiello, F. M., et al. (1993) Molecular diagnosis of familial adenomatous polyposis. N. Engl. J. Med. 329, 1982–1987.PubMedCrossRefGoogle Scholar
- 3.Rowan, A. J. and Bodmer, W. F. (1997) Introduction of a myc reporter tag to improve the quality of mutation detection using the protein truncation test. Hum. Mutat. 9, 172–176.PubMedCrossRefGoogle Scholar
- 4.Becker, K.-F., Reich, U., Handschuh, G., Dalke, C., and Höfler, H. (1996) Non-radioactive protein truncation test (nrPTT) for rapid detection of gene mutations. Trends Genet. 12, 250.PubMedCrossRefGoogle Scholar
- 5.Gardner, R. J., Bobrow, M., and Roberts, R. G. (1995) The identification of point mutations in Duchenne muscular dystrophy by using reverse-transcription PCR and the protein truncation test. Am. J. Hum. Genet. 57, 311–320.PubMedGoogle Scholar
- 6.Whittock, N. V., Roberts, R. G., Mathew, C. G., and Abbs, S. J. (1997) Dystrophin point mutation screening using a multiplexed protein truncation test. Genet. Test. 1, 115–123.PubMedCrossRefGoogle Scholar
- 7.van der Luijt, R., Khan, P. M., Vasen, H., Van Leeuwen, C., Tops, C., Roest, P., et al. (1994) Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test. Genomics 20, 1–4.PubMedCrossRefGoogle Scholar
- 8.Prosser, J., Condie, A., Wright, M., Horn, J. M., Fantes, J. A., Wyllie, A. H., et al. (1994) APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis. Br. J. Cancer 70, 841–846.PubMedCrossRefGoogle Scholar
- 9.Hogervorst, F. B. L., Cornelis, R. S., Bout, M., van Vliet, M., Oosterwijk, J. C., Olmer, R., et al. (1995) Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genetics 10, 208–212.PubMedCrossRefGoogle Scholar
- 10.Plummer, S. J., Anton-Culver, H., Webster, L., Noble, B., Liao, S., Kennedy, A., et al. (1995) Detection of BRCA1 mutations by the protein truncation test. Hum. Mol. Genet. 4, 1989–1991.PubMedCrossRefGoogle Scholar
- 11.Garvin, A. M. (1998) A complete protein truncation test for BRCA1 and BRCA2. Eur. J. Hum. Genet. 6, 226–234.PubMedCrossRefGoogle Scholar
- 12.Garvin, A. M., Attenhofer-Haner, M., and Scott, R.J. (1997) BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients. J. Med. Genet. 34, 990–995.PubMedCrossRefGoogle Scholar
- 13.Friedman, L. S., Gayther, S. A., Kurosaki, T., Gordon, D., Noble, B., Casey, G., et al. (1997) Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am. J. Hum. Genet. 60, 313–319.PubMedGoogle Scholar
- 14.Kohonen-Corish, M., Ross, V. L., Doe, W. F., Kool, D. A., Edkins, E., Faragher, I., et al. (1996) RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. Am. J. Hum. Genet. 59, 818–824.PubMedGoogle Scholar
- 15.Lui, B., Parsons, R. E., Hamilton, S. R., Petersen, G. M., Lynch, H. T., Watson, P., et al. (1994) hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res. 54, 4590–4594.Google Scholar
- 16.Romey, M.-C., Tuffery, S., Desgeorges, M., Bienvenu, T., Demaille, J., and Clautres, M. (1996) Transcript analysis of CFTR frameshift mutations in lymphocytes using the reverse transcription-polymerase chain reaction and the protein truncation test. Hum. Genet. 98, 328–332.PubMedCrossRefGoogle Scholar
- 17.Heim, R. A., Kam-Morgan, L. N. W., Binnie, C. G., Corns, D. D., Cayouette, M. C, Farber, R. A., et al. (1995) Distribution of 13 truncating mutations in the neu-rofibromatosis 1 gene. Hum. Mol. Genet. 4, 975–981.PubMedCrossRefGoogle Scholar
- 18.van Bakel, I., Sepp, T., Ward, S., Yates, J. R. W., and Green, A. J. (1997) Mutations in the TSC2 gene: analysis of the complete coding sequence using the protein truncation test (PTT). Hum. Mol. Genet. 6, 1409–1414.PubMedCrossRefGoogle Scholar
- 19.Peral, B., Gamble, V., Strong, C., Ong, A. C. M., Sloane-Stanley, J., Zerres, K., et al. (1997) Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach. Am. J. Hum. Genet. 60, 1399–1410.PubMedCrossRefGoogle Scholar
- 20.Fitzgerald, M. G., Bean, J. M., Hegde, S. R., Unsal, H., MacDonald, D. J., Harkin, D. P., et al. (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genet. 15, 307–310.PubMedCrossRefGoogle Scholar
- 21.Axton, R., Hanson, I., Danes, S., Sellar, G., van Heyningen, V., and Prosser, J. (1997)The incidence of PAX6 mutation in patients with simple aniridia: an evaluation of mutation detection in 12 cases. J. Med. Genet. 34, 279–286.PubMedCrossRefGoogle Scholar
- 22.Hogervorst, F. B. L. (1998) Protein truncation test (PTT). Promega Notes 62, 7–10.Google Scholar
- 23.Lo Ten Foe, J. R., Rooimans, M. A., Bosnoyan-Collins, L., Alon, N., Wijker, M., Parker, L., et al. (1996) Expression cloning of a cDNA for the major fanconi anaemia gene FAA. Nature Genet. 14, 320–323PubMedCrossRefGoogle Scholar
- 24.Claes, K., Macháckova, E., Callens, T., Van der Cruyssen, G., and Messiaen, L. (1998) Improved conditions for PTT analysis of the BRCA1, BRCA2, NF1 and APC genes. Elsevier Trends Journals Technical Tips Online, T01457, 22/7/98. Available.Google Scholar
- 25.Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.Google Scholar